APM
TWST icon

Avidity Partners Management’s Twist Bioscience TWST Stock Holding History

Avidity Partners Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-819,000
Closed -$12.4M – 108
2023
Q1 		$12.4M Buy
819,000
+208,000
+34% +$4.59M 0.41% 64
2022
Q4 		$14.5M Buy
+611,000
New +$17.7M 0.32% 58

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Avidity Partners Management's TWST Position: Q2 2023 in Review

Avidity Partners Management sold out of Twist Bioscience (TWST) in Q2 2023, closing a stake of 819,000 shares — an estimated $12.4M sold.

Avidity Partners Management first reported a position in TWST in Q4 2022 and held it in 2 quarters. The position peaked at $14.5M in Q4 2022. 193 funds tracked by Wall St. Rank hold TWST as of Q2 2023.

  • Avidity Partners Management reported no remaining Twist Bioscience position as of Q2 2023 after selling out during the quarter.
  • Avidity Partners Management sold 819,000 Twist Bioscience shares in Q2 2023, an estimated $12.4M.
  • Avidity Partners Management first reported a position in Twist Bioscience in Q4 2022 and held it in 2 quarters.
  • Avidity Partners Management's Twist Bioscience position peaked at $14.5M in Q4 2022.
  • 193 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2023.

Based on Avidity Partners Management's 13F filing for Q2 2023, filed 14 Aug 2023.